Alkermes

$18.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.24 (-1.26%) Today
-$0.03 (-0.14%) As of 9:30 PM UTC after-hours

Why Robinhood?

You can buy or sell Alkermes and other stocks, options, and ETFs commission-free!

About ALKS

Alkermes plc Ordinary Shares, also called Alkermes, is a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include Aristada, which is used for the treatment of schizophrenia in adults; and Vivitrol, which is an injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification.

CEO
Richard F. Pops
Employees
2,245
Headquarters
Dublin, Dublin
Founded
2011
Market Cap
3.00B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.01M
High Today
$18.98
Low Today
$18.43
Open Price
$18.92
Volume
1.15M
52 Week High
$23.92
52 Week Low
$13.03

ALKS Earnings

-$0.21
$0.14
$0.48
$0.83
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 28, Pre-Market

You May Also Like

DCP-B
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure